SEARCH

SEARCH BY CITATION

References

  • 1
    Aisenberg, A. C.: Malignant lymphoma, N. Engl. J. Med. 288: 883890 and 288:935–941, 1973.
  • 2
    Benjamin, R. S., Wiernik, P. H., and Bachur, N. R.: Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high close schedule. Cancer 33: 1927, 1974.
  • 3
    Cutler, S., and Ederer, F.: Maximum utilization of the life-table method in analyzing survival. J. Chronic Dis. 8: 699712, 1968.
  • 4
    Durant, J. R., Lessner, H. E., Loeb, V., and Velez-Garcia, E.: BCNU-cyclophosphamide therapy for mixed (MLHL) and histiocytic (HL) lymphoma and Hodgkin's disease (HD). Proc. Am. Soc. Clin. Oncol. April 10, 1973. (Abstract)
  • 5
    Durant, J. R., and Lessner, H. E.: Development of four-drug BCNU combination chemotherapy regimens. Cancer 32: 277285, 1973.
  • 6
    Gehan, E. A.: A generalized wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52: 203223, 1965.
  • 7
    Huguley, C. M., Jr., Durant, J. R., Moores, R. R., Chan, Y. K., Dorfman, R., and Johnson, L.: A comparison of the effectiveness in advanced Hodgkin's disease of a combination of drugs and of a single agent both given intensively over a six month period. Cancer 36: 12271240, 1975.
  • 8
    Jones, S. E., Fuks, Z., Bull, M., Kadin, M. E., Dorfman, R. F., Kaplan, H. S., Rosenberg, S. A., and Kim, H.: Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer 31: 806823, 1973.
  • 9
    Lenhard, R. D., and Owens, A. H.: Prednisone in combination chemotherapy of lymphoma. Proc. Am. Assoc. Cancer Res., 12: 35, 1971.
  • 10
    Lessner, H. E.: BCNU (1,2 bis(2-chloroethyl)-1-nitrosurea) effects in advanced Hodgkin's disease and other neoplasia. Cancer 22: 451456, 1968.
  • 11
    Levitt, M., Marsh, J. C., DeConti, R. C., Mitchell, M. S., Skeel, R. T., Farber, L. R., and Bertino, J. R.: Combination sequential chemotherapy in advanced reticulum cell sarcoma. Cancer 29: 630635, 1972.
  • 12
    Livingston, R. B., and Carter, S. K.: Single Agents in Cancer Chemotherapy. New York, Plenum Press, 1970; p. 229.
  • 13
    Lowenbraun, S., DeVita, V. T., and Serpick, A. A.: Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma. Cancer 25: 10181025, 1970.
  • 14
    Luce, J. K., Gamble, J. F., Wilson, H. E., Monto, R. W., Isaacs, B. L., Palmer, R. L.: Coltman, C. A., Hewlett, J. S., Gehan, E. A., and Frei, E., III: Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma. Cancer 28: 306317, 1971.
  • 15
    Luce, J. C., Frei, E. III, Gehan, E. A., and Coltman, C. R., Jr.: Concurrent comparison of three multiple drug regimens in chemotherapy of non-Hodgkin's lymphoma. Proc. Am. Soc. Clin. Oncol. May 3, 1972, 41. (Abstract)
  • 16
    Rappaport, H.: Tumors of the hematopoietic system. In Atlas of Tumor Pathology Section 3, Fasc 8. Washington, DC, Armed Forces Institute of Pathology, 1966; p. 13.
  • 17
    Rosenberg, S. A.: Report of the committee on the staging of Hodgkin's disease. Cancer Res., 26: 1310, 1966.
  • 18
    Schein, P. S., Chabner, B., Canellos, G., Young, R. C., Berard, C., and DeVita, V. T.: Potential for prolonged disease free survival following combination chemotherapy of non-Hodgkin's lymphoma. Blood 43: 181189, 1974.
  • 19
    Talley, R. W., et al.: Clinical pharmacology and human anti-tumor activity of cytosine arabinosis. Cancer, 20: 809, 1967.
  • 20
    Valeriote, F. A., Bruce, W. R., and Meeker, B. E.: Synergistic action of cyclophosphamide and 1,3 bis-(2-chloroethyl)-1-nitrosourea on the transplanted murine lymphoma. J. Natl. Cancer Inst. 40: 935944, 1968.
  • 21
    Yagoda, A., Krakoff, I., LaMonte, C., and Tan, C.: Clinical trial of bleomycin. Proc. Am. Assoc. Cancer Res., 12: 37, 1971. (Abstract).